These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1966946)

  • 1. Soluble CD8 antigen in systemic sclerosis.
    Famularo G; Giacomelli R; Sacchetti S; Danese C; Luciani AM; Perego MA; Tonietti G
    J Clin Lab Immunol; 1990 Jul; 32(3):109-12. PubMed ID: 1966946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
    Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
    J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in Crohn's disease, celiac disease, and systemic lupus erythematosus.
    Srivastava MD; Rossi TM; Lebenthal E
    Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):21-6. PubMed ID: 7735726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated in vivo and in vitro secretion of CD8-alpha molecules in patients with systemic lupus erythematosus.
    Linker-Israeli M; Hyun S; Ozeri-Chen T; Wallace DJ; Banks K; Klinenberg JR
    J Immunol; 1994 Mar; 152(6):3158-67. PubMed ID: 8144910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum soluble interleukin 2 receptor alpha and soluble CD8 levels in patients with gynecological malignancies undergoing radiotherapy.
    Frydecka I; Rusiecka M; Kuliczkowski K; Kornafel J
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):123-6. PubMed ID: 8915516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR antigens in progressive systemic sclerosis (scleroderma).
    Whiteside TL; Medsger TA; Rodnan GP
    J Rheumatol; 1983 Feb; 10(1):128-31. PubMed ID: 6601709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased transendothelial migration of scleroderma lymphocytes.
    Stummvoll GH; Aringer M; Grisar J; Steiner CW; Smolen JS; Knobler R; Graninger WB
    Ann Rheum Dis; 2004 May; 63(5):569-74. PubMed ID: 15082489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Vdelta1+ T cells are activated and accumulate in the skin of systemic sclerosis patients.
    Giacomelli R; Matucci-Cerinic M; Cipriani P; Ghersetich I; Lattanzio R; Pavan A; Pignone A; Cagnoni ML; Lotti T; Tonietti G
    Arthritis Rheum; 1998 Feb; 41(2):327-34. PubMed ID: 9485091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).
    Barnett AJ; Tait BD; Barnett MA; Toh BH
    Clin Exp Immunol; 1989 Apr; 76(1):24-9. PubMed ID: 2525437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of epidermal Langerhans' cells and endothelial cell HLA-DR antigens in the skin in progressive systemic sclerosis.
    Andrews BS; Friou GJ; Barr RJ; Mirick GR; Berman M; Sandborg C; Ross PA
    J Rheumatol; 1986 Apr; 13(2):341-8. PubMed ID: 2941574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity.
    Wenzel J; Henze S; Brähler S; Bieber T; Tüting T
    Exp Dermatol; 2005 Jun; 14(6):454-9. PubMed ID: 15885081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Coexpression of CD4 and CD8 antigens and the appearance of HLA-DR and CD25 receptors on lymphocytes as markers of immune activation in patients with HIV infection].
    Radkowski M; Sadowska M; Kopicz-Kamińska E; Horban A; Slusarczyk J
    Pol Merkur Lekarski; 1996 Nov; 1(5):325-6. PubMed ID: 9273207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis.
    Tsuji-Yamada J; Nakazawa M; Minami M; Sasaki T
    J Rheumatol; 2001 Jun; 28(6):1252-8. PubMed ID: 11409116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of an activated, profibrotic pattern of gene expression in lung CD8+ T cells from scleroderma patients.
    Luzina IG; Atamas SP; Wise R; Wigley FM; Choi J; Xiao HQ; White B
    Arthritis Rheum; 2003 Aug; 48(8):2262-74. PubMed ID: 12905481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Soluble receptors of cytokines in sera of patients with systemic sclerosis--clinical correlation].
    Lis AD; Brzezińska-Wcisło LA
    Wiad Lek; 2003; 56(11-12):532-6. PubMed ID: 15058159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.